UNIVERSITY OF UTAH

UNIVERSITY OF UTAH logo
🇺🇸United States
Ownership
Private
Established
1850-02-28
Employees
10K
Market Cap
-
Website
http://www.utah.edu
Clinical Trials
Related News

Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT

First Posted Date
2008-01-03
Last Posted Date
2018-04-05
Lead Sponsor
University of Utah
Target Recruit Count
28
Registration Number
NCT00585182
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

CRT Pilot Study for Children With Heart Failure

First Posted Date
2008-01-03
Last Posted Date
2023-05-11
Lead Sponsor
University of Utah
Target Recruit Count
7
Registration Number
NCT00585065
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Effects of Vitamin D on Renin Expression in Hypertensive Patients

Early Phase 1
Terminated
Conditions
Hypertension
Vitamin D Deficiency
Interventions
Drug: calcitriol
Drug: Placebo
First Posted Date
2008-01-03
Last Posted Date
2016-05-27
Lead Sponsor
University of Utah
Target Recruit Count
12
Registration Number
NCT00585442
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients

First Posted Date
2008-01-03
Last Posted Date
2017-02-10
Lead Sponsor
University of Utah
Target Recruit Count
8
Registration Number
NCT00585221
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer

Phase 2
Completed
Conditions
Cancer
Interventions
Drug: Bevacizumab and Erlotinib
First Posted Date
2008-01-03
Last Posted Date
2015-09-24
Lead Sponsor
University of Utah
Target Recruit Count
50
Registration Number
NCT00585377
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

The Effects of Celecoxib on Bone Ingrowth

Early Phase 1
Terminated
Conditions
Bone Ingrowth
Pain
Interventions
Drug: Celecoxib
First Posted Date
2008-01-03
Last Posted Date
2016-03-14
Lead Sponsor
University of Utah
Target Recruit Count
9
Registration Number
NCT00585156
Locations
🇺🇸

Veteran Affairs (VA) Medical Center, Salt Lake City, Utah, United States

Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

Phase 4
Completed
Conditions
Kidney Transplantation
Interventions
Drug: Myfortic
First Posted Date
2008-01-03
Last Posted Date
2016-05-06
Lead Sponsor
University of Utah
Target Recruit Count
21
Registration Number
NCT00585468
Locations
🇺🇸

Univ of Utah-Solid Organ Transplant, Salt Lake City, Utah, United States

Tools for the Objective Clinical Assessment of Pediatric Spinal Deformity

First Posted Date
2008-01-03
Last Posted Date
2024-01-09
Lead Sponsor
University of Utah
Registration Number
NCT00585234
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease

Completed
Conditions
End Stage Renal Disease
First Posted Date
2007-12-03
Last Posted Date
2016-08-11
Lead Sponsor
University of Utah
Target Recruit Count
145
Registration Number
NCT00566670
Locations
🇺🇸

Vanderbilt University Medical Centet, Nashville, Tennessee, United States

🇺🇸

University of Utah, Salt Lake City, Utah, United States

Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy

Phase 1
Completed
Conditions
Spinal Muscular Atrophy
Interventions
Drug: Sodium phenylbutyrate (NaPB)
First Posted Date
2007-09-12
Last Posted Date
2015-07-03
Lead Sponsor
University of Utah
Target Recruit Count
14
Registration Number
NCT00528268
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy